Cargando…
Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631647/ https://www.ncbi.nlm.nih.gov/pubmed/35443022 http://dx.doi.org/10.1182/bloodadvances.2021006468 |
| _version_ | 1784823859415875584 |
|---|---|
| author | Uy, Geoffrey L. Newell, Laura F. Lin, Tara L. Goldberg, Stuart L. Wieduwilt, Matthew J. Ryan, Robert J. Faderl, Stefan Lancet, Jeffrey E. |
| author_facet | Uy, Geoffrey L. Newell, Laura F. Lin, Tara L. Goldberg, Stuart L. Wieduwilt, Matthew J. Ryan, Robert J. Faderl, Stefan Lancet, Jeffrey E. |
| author_sort | Uy, Geoffrey L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9631647 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96316472022-11-04 Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML Uy, Geoffrey L. Newell, Laura F. Lin, Tara L. Goldberg, Stuart L. Wieduwilt, Matthew J. Ryan, Robert J. Faderl, Stefan Lancet, Jeffrey E. Blood Adv Research Letter American Society of Hematology 2022-08-29 /pmc/articles/PMC9631647/ /pubmed/35443022 http://dx.doi.org/10.1182/bloodadvances.2021006468 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
| spellingShingle | Research Letter Uy, Geoffrey L. Newell, Laura F. Lin, Tara L. Goldberg, Stuart L. Wieduwilt, Matthew J. Ryan, Robert J. Faderl, Stefan Lancet, Jeffrey E. Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML |
| title | Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML |
| title_full | Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML |
| title_fullStr | Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML |
| title_full_unstemmed | Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML |
| title_short | Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML |
| title_sort | transplant outcomes after cpx-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary aml |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631647/ https://www.ncbi.nlm.nih.gov/pubmed/35443022 http://dx.doi.org/10.1182/bloodadvances.2021006468 |
| work_keys_str_mv | AT uygeoffreyl transplantoutcomesaftercpx351vs73inolderadultswithnewlydiagnosedhighriskandorsecondaryaml AT newelllauraf transplantoutcomesaftercpx351vs73inolderadultswithnewlydiagnosedhighriskandorsecondaryaml AT lintaral transplantoutcomesaftercpx351vs73inolderadultswithnewlydiagnosedhighriskandorsecondaryaml AT goldbergstuartl transplantoutcomesaftercpx351vs73inolderadultswithnewlydiagnosedhighriskandorsecondaryaml AT wieduwiltmatthewj transplantoutcomesaftercpx351vs73inolderadultswithnewlydiagnosedhighriskandorsecondaryaml AT ryanrobertj transplantoutcomesaftercpx351vs73inolderadultswithnewlydiagnosedhighriskandorsecondaryaml AT faderlstefan transplantoutcomesaftercpx351vs73inolderadultswithnewlydiagnosedhighriskandorsecondaryaml AT lancetjeffreye transplantoutcomesaftercpx351vs73inolderadultswithnewlydiagnosedhighriskandorsecondaryaml |